ERBB3 and neoplasm: Next to BCL3, ERBB2/3 (Her2/Her3) are also downregulated upon miR-125b overexpression in human ovarian cancer cell lines, further demonstrating that this pathway is involved in the development of multiple tumor types in which miR-125b is tumor suppressive.